[1]刘嘉慧,张 萍,曹瑾音,等.基于K-means算法的 病种成本聚类分析及精细化管理探究[J].卫生经济研究,2024,41(08):37-40,44.
 LIU Jiahui,ZHANG Ping,CAO Jinyin,et al.Study on Clustering Analysis and Refined Management of Disease Cost based on K-means Algorithm[J].Journal Press of Health Economics Research,2024,41(08):37-40,44.
点击复制

基于K-means算法的 病种成本聚类分析及精细化管理探究
分享到:

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年08期
页码:
37-40,44
栏目:
成本与费用
出版日期:
2024-08-01

文章信息/Info

Title:
Study on Clustering Analysis and Refined Management of Disease Cost based on K-means Algorithm
作者:
刘嘉慧1张 萍1曹瑾音1张芷菁1
1.中山大学附属第一医院,广东 广州 510080
Author(s):
LIU Jiahui ZHANG Ping CAO Jinyin ZHANG Zhijing
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou Guangdong 510080, China
关键词:
聚类分析病种成本精细化管理
Keywords:
cluster analysis disease cost refined management
分类号:
R197
文献标志码:
A
摘要:
目的:探索构建基于“投入-产出-频次”三个维度的病种成本分析模型,完善以病种为基础、以价值为导向的医院运营管理体系,助力精细化管理水平提升。方法:以某三甲医院为样本,基于某年度病案首页数据,运用 K-means算法对病种进行聚类分析。结果:将病种聚类为六类,从整体来看样本医院病种结构较好,但基层病种占比仍较大。结论:医院可以对病种进行精细化分类管理,对“重要价值病种”给予资源倾斜,对“一般价值病种”优化诊疗流程和模式,同时开展病种成本监测及分析,控制成本。
Abstract:
Objective To construct a disease cost analysis model based on the three dimensions of "input-output-frequency", to improve the disease-based and value-oriented operation management system for hospitals, and to help improve the level of refined management. Methods Taking a tertiary hospital as a sample, based on the data of the first page from medical records in a certain year, the K-means algorithm was applied to analyze the clustering of disease types. Results The disease types were clustered into six categories. From the overall point of view, the sample hospital had a better disease type structure, but the proportion of low-value disease types was still larger. Conclusion It is necessary to refine the classification and management of disease types in hospitals, give resources to "high-value disease types", optimize the diagnosis and treatment process and mode of the "general-value disease types", and carry out the monitoring and analysis of disease cost to control the cost.

参考文献/References:

[1] 徐庆峰,武启峰,赵晨,等.公立医院DRG病组成本-效益分析探索[J].中国卫生经济,2022,41(08):83-88.
[2] 刘玥,赵凯,魏明丽.DRG支付下公立医院精细化成本管控的实证研究[J].卫生经济研究,2022,39(03):83-87.
[3] 陶莹,杨锋,刘洋,等.K均值聚类算法的研究与优化[J].计算机技术与发展,2018,28(06):90-92.
[4] Tibshirani R,Walther G,Hastie T.Estimating the number of cluster in a dataset via the gap statistic[J].Journal of the Royal Statistical Society,2001,63(02) :411-423.
[5] 窦婷,张正军.基于IGS方法的最佳分类数研究[J].重庆工商大学学报(自然科学版),2017,34(06):29-33.
[6] 陈默,蔡苗,黄阿红,等.基于K-means聚类与支持向量机的大病患者住院费用影响因素与控制策略研究[J].中国医院管理,2019,39(05):45-47,53.
[7] 张芷菁,张萍,曹瑾音,等.DIP支付改革下病种成本分析模型研究[J].现代医院,2023,23(09):1380-1383,1386.
[8] 李彤宇,李星,王强.DRG支付下公立医院成本运营及效益提升路径研究[J].卫生经济研究,2023,40(07):79-81,85.
[9] 刘艳,张丽华,王虎,等.按病种付费制度下武汉市某医院单病种成本效益分析[J].医学与社会,2019,32(09):90-92,101.
[10] 曾雪琴,黄伟,于伟.DIP核心病种分类管理模式构建与实践[J].卫生经济研究,2023,40(10):66-69,73.
[11] 郑佳,伍冀湘,王宁利,等.我院开展日间手术的效果评价与分析[J].中国医院管理,2014,34(08):27-29.
[12] 马戈,朱华洁,夏琦琦.平台式日间化学治疗中心建设经验分享[J].华西医学,2023,38(02):295-299.

相似文献/References:

[1]常峰,夏强,崔鹏磊,等.城镇职工基本医疗保险基金持续运行能力评价[J].卫生经济研究,2016,(02):13.
[2]冯海欢,李天俊,滕世伟,等.异地就医联网结算医保病人特征聚类分析[J].卫生经济研究,2018,(07):51.
[3]胡文杰,刘 明,徐俊英,等.医院病种成本核算的实践及探索[J].卫生经济研究,2018,(07):54.
[4]张永征,崔伟萍,张 琳,等.加强医院运营管理路径研究——基于医疗项目成本及病种成本核算结果应用的视角[J].卫生经济研究,2019,(04):40.
 ZHANG Yong-zheng,CUI Wei-ping,ZHANG Lin,et al.Study of Strengthening Hospital Operation Management Path——Based on the Application of Medical Project Cost and Disease Cost Accounting Results[J].Journal Press of Health Economics Research,2019,(08):40.
[5]杨 敏,王 前.新医改以来我国DRG研究热点的聚类分析[J].卫生经济研究,2019,(08):35.
 YANG Min,WANG Qian.Cluster Analysis of Hot Spots of DRG Research in China since the New Medical Reform[J].Journal Press of Health Economics Research,2019,(08):35.
[6]郑 晨sup>.DRG/DIP付费下的医院成本管理[J].卫生经济研究,2022,39(3):88.
 ZHENG Chen.Hospital Cost Management Under DRG/DIP Payment[J].Journal Press of Health Economics Research,2022,39(08):88.
[7]马继飞,张文龙.粤港澳大湾区中医药健康产业高质量发展研究[J].卫生经济研究,2023,40(4):24.
 MA Jifei,ZHANG Wenlong.Study on the High-quality Development of TCM Health Industry in Guangdong-Hong Kong-Macao Greater Bay Area[J].Journal Press of Health Economics Research,2023,40(08):24.
[8]赵 悦,梁 旭,王 锐,等.辽宁省中医发展现状及规划研究[J].卫生经济研究,2023,40(6):64.
 ZHAO Yue,LIANG Xu,WANG Rui,et al.Study on the Current Situation and Development Planning of Traditional Chinese Medicine in Liaoning Province[J].Journal Press of Health Economics Research,2023,40(08):64.
[9]陈志军,包维晔,沈思远,等.基于临床路径的儿科病种成本收益研究[J].卫生经济研究,2023,40(8):49.
 CHEN Zhijun,BAO Weiye,SHEN Siyuan,et al.Study on Cost and Benefit of Pediatric Diseases based on Clinical Pathway[J].Journal Press of Health Economics Research,2023,40(08):49.

更新日期/Last Update: 2024-08-01